Birgitte Oppers‐Walgreen

3.0k citations
17 papers · 2.5k · 1 hit paper · h-index 15

Impact in

  • Immunology top 2%
    • Psoriasis: Treatment and Pathogenesis
    • T-cell and B-cell Immunology
    • Immune Response and Inflammation
  • Rheumatology top 1%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research

Papers in

  • Rheumatology 6
    • Rheumatoid Arthritis Research and Therapies 5
  • Immunology 5
    • Psoriasis: Treatment and Pathogenesis 2
    • Immune Response and Inflammation 2
Co-authors
Leo A. B. Joosten (13 shared papers)Wim B. van den Berg (12 shared papers)Erik Lubberts (9 shared papers)Liduine van den Bersselaar (7 shared papers)Marije I. Koenders (7 shared papers)Christina J. J. Coenen‐de Roo (2 shared papers)Jay K. Kolls (4 shared papers)Timothy R. D. J. Radstake (3 shared papers)
Journals
American Journal Of Pathology (3 papers)The Journal of Immunology (2 papers)Journal of Orthopaedic Research® (1 paper)Proceedings of the National Academy of Sciences (1 paper)Annals of the Rheumatic Diseases (1 paper)
Partner nations
NetherlandsUnited StatesSwitzerland

In The Last Decade

Birgitte Oppers‐Walgreen

17 papers receiving 2.4k citations

Birgitte Oppers‐Walgreen's Hit Papers

Treatment with a neutralizing anti‐murine interleukin‐17 antibody after the onset of collagen‐induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion 2004 · 600 citations
6000+7+14Years since publication200400600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2004 Arthritis & Rheumatism

Peers

Birgitte Oppers‐Walgreen
Comparison fields: 5 of 87
  • Immunology 1.2k
  • Rheumatology 732
  • Hematology 234
  • Oncology 531
  • Nephrology 89
Replace Michael Bonelli with:
Michael Bonelli Austria
Peggy Jacques Belgium
Manjiri Sathe United States
Martine Chabaud France
Lisa G. M. van Baarsen Netherlands
Shigeru Ishiyama Japan
Liduine van den Bersselaar Netherlands
Stefan Kuchen Switzerland
Yojiro Kawabe Japan
Sylvie Ferrari‐Lacraz Switzerland
Birgitte Oppers‐Walgreen relative to Michael Bonelli Austria Michael Bonelli's profile →
Citations per field
00.5×2×3.2×
Michael Bonelli · 1×
Citations per year

Countries citing papers authored by Birgitte Oppers‐Walgreen

Since Specialization
Citations

This map shows the geographic impact of Birgitte Oppers‐Walgreen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitte Oppers‐Walgreen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitte Oppers‐Walgreen more than expected).

Fields of papers citing papers by Birgitte Oppers‐Walgreen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitte Oppers‐Walgreen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitte Oppers‐Walgreen. The network helps show where Birgitte Oppers‐Walgreen may publish in the future.

Co-authors

The 25 scholars most cited alongside Birgitte Oppers‐Walgreen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Birgitte Oppers‐Walgreen Line = papers co-authored together Birgitte Oppers‐Walgreen links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Treatment with a neutralizing anti‐murine interleukin‐17 antibody after the onset of collagen‐induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion
Arthritis & Rheumatism ·Erik Lubberts, Marije I. Koenders, Birgitte Oppers‐Walgreen, Liduine van den Bersselaar, Christina J. J. Coenen‐de Roo, Leo A. B. Joosten, Wim B. van den Berg
Hit paper breakdown →		2004600
2
IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance
The Journal of Immunology ·Erik Lubberts, Liduine van den Bersselaar, Birgitte Oppers‐Walgreen, Paul Schwarzenberger, Christina J. J. Coenen‐de Roo, Jay K. Kolls, Leo A. B. Joosten, Wim B. van den Berg
2003285
3
Expression of Toll‐like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin‐12 and interleukin‐18 via interferon‐γ
Arthritis & Rheumatism ·Timothy R. D. J. Radstake, Mieke F. Roelofs, Y.M. Bastiaansen-Jenniskens, Birgitte Oppers‐Walgreen, Piet L. C. M. van Riel, Pilar Barrera, Leo A. B. Joosten, Wim B. van den Berg
2004280
4
IL-32, a proinflammatory cytokine in rheumatoid arthritis
Proceedings of the National Academy of Sciences ·Leo A. B. Joosten, Mihai G. Netea, Soohyun Kim, Do‐Young Yoon, Birgitte Oppers‐Walgreen, Timothy R. D. J. Radstake, Pilar Barrera, Fons A. J. van de Loo, Charles A. Dinarello, Wim B. van den Berg
2006277
5
Blocking of Interleukin-17 during Reactivation of Experimental Arthritis Prevents Joint Inflammation and Bone Erosion by Decreasing RANKL and Interleukin-1
American Journal Of Pathology ·Marije I. Koenders, Erik Lubberts, Birgitte Oppers‐Walgreen, Liduine van den Bersselaar, Monique M. Helsen, Franco E. Di Padova, Annemieke M. H. Boots, Hermann Gram, Leo A. B. Joosten, Wim B. van den Berg
2005246
6
Interleukin‐17 receptor deficiency results in impaired synovial expression of interleukin‐1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall–induced arthritis
Arthritis & Rheumatism ·Marije I. Koenders, Jay K. Kolls, Birgitte Oppers‐Walgreen, Liduine van den Bersselaar, Leo A. B. Joosten, Jill R. Schurr, Paul Schwarzenberger, Wim B. van den Berg, Erik Lubberts
2005158
7
Interleukin-17 Acts Independently of TNF-α under Arthritic Conditions
The Journal of Immunology ·Marije I. Koenders, Erik Lubberts, Fons A. J. van de Loo, Birgitte Oppers‐Walgreen, Liduine van den Bersselaar, Monique M. Helsen, Jay K. Kolls, Franco E. Di Padova, Leo A. B. Joosten, Wim B. van den Berg
200698
8
Expression of Agrin, Dystroglycan, and Utrophin in Normal Renal Tissue and in Experimental Glomerulopathies
American Journal Of Pathology ·C.J.I. Raats, Jacob van den Born, Marinka A.H. Bakker, Birgitte Oppers‐Walgreen, Brenda J.M. Pisa, Henry Dijkman, Karel J.M. Assmann, Jo H. M. Berden
200090
9
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)
Annals of the Rheumatic Diseases ·Mieke F. Roelofs, Mark H. Wenink, Fabia Brentano, Shahla Abdollahi‐Roodsaz, Birgitte Oppers‐Walgreen, Pilar Barrera, Piet L. C. M. van Riel, Leo A. B. Joosten, Diego Kyburz, Wim B. van den Berg, Timothy R. D. J. Radstake
200888
10
Induction of cartilage damage by overexpression of T cell interleukin‐17A in experimental arthritis in mice deficient in interleukin‐1
Arthritis & Rheumatism ·Marije I. Koenders, Erik Lubberts, Birgitte Oppers‐Walgreen, Liduine van den Bersselaar, Monique M. Helsen, Jay K. Kolls, Leo A. B. Joosten, Wim B. van den Berg
200576
11
T cell dependence of chronic destructive murine arthritis induced by repeated local activation of toll‐like receptor–driven pathways: Crucial role of both interleukin‐1β and interleukin‐17
Arthritis & Rheumatism ·Leo A. B. Joosten, Shahla Abdollahi‐Roodsaz, Marleen Heuvelmans‐Jacobs, Monique M. Helsen, L. A. M. Van Den Bersselaar, Birgitte Oppers‐Walgreen, Marije I. Koenders, Wim B. van den Berg
200770
12
Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
American Journal Of Pathology ·Leo A. B. Joosten, Ruben L. Smeets, Marije I. Koenders, L. A. M. Van Den Bersselaar, Monique M. Helsen, Birgitte Oppers‐Walgreen, Erik Lubberts, Yoichiro Iwakura, Fons A. J. van de Loo, Wim B. van den Berg
200469
13
Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: Effects of disease progression and lipopolysaccharide administration
Arthritis & Rheumatism ·Rudi Licht, Mieke C.J. van Bruggen, Birgitte Oppers‐Walgreen, Truus P. M. Rijke, Jo H. M. Berden
200168
14
Increase in expression of receptor activator of nuclear factor κB at sites of bone erosion correlates with progression of inflammation in evolving collagen‐induced arthritis
Arthritis & Rheumatism ·Erik Lubberts, Birgitte Oppers‐Walgreen, Allison R. Pettit, Liduine van den Bersselaar, Leo A. B. Joosten, Steven R. Goldring, Ellen M. Gravallese, Wim B. van den Berg
200260
15
Tendon degeneration is not mediated by regulation of Toll‐like receptors 2 and 4 in human tenocytes
Journal of Orthopaedic Research® ·Marieke de Mos, Leo A. B. Joosten, Birgitte Oppers‐Walgreen, J T M van Schie, Holger Jahr, Gerjo J.V.M. van Osch, Jan A.N. Verhaar
200918
16
IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
Arthritis Research ·Shahla Abdollahi‐Roodsaz, LAB Joosten, MF Roelofs, MMA Helsen, Birgitte Oppers‐Walgreen, CHM Arndtz, TRDJ Radstake, WB van den Berg
20052
17
IL-18 expression in synovial biopsies of patients with active rheumatoid arthritis is associated with enhanced levels of both IL-1 and TNFα
Arthritis Research ·LAB Joosten, Pilar Barrera, Erik Lubberts, A. Blom, Birgitte Oppers‐Walgreen, LAM van den Bersselaa, WB van den Berg
20021

About Birgitte Oppers‐Walgreen

Birgitte Oppers‐Walgreen is a scholar working on Rheumatology, Immunology, Molecular Biology, Cancer Research and Oncology, having authored 17 papers that have together received 2.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), NF-κB Signaling Pathways (3 papers), Bone Metabolism and Diseases (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Immune Response and Inflammation (2 papers) and Pharmacological Effects of Natural Compounds (1 paper). The work is most often cited by research in Immunology (1.2k citations), Rheumatology (732 citations), Hematology (234 citations), Oncology (531 citations) and Nephrology (89 citations). Birgitte Oppers‐Walgreen has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Leo A. B. Joosten, Wim B. van den Berg, Erik Lubberts, Liduine van den Bersselaar, Marije I. Koenders, Christina J. J. Coenen‐de Roo, Jay K. Kolls, Timothy R. D. J. Radstake, Pilar Barrera and Monique M. Helsen. Their work appears in journals such as American Journal Of Pathology, The Journal of Immunology, Journal of Orthopaedic Research®, Proceedings of the National Academy of Sciences and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael BonelliBreakdown of academic impact, for papers by Peggy JacquesBreakdown of academic impact, for papers by Manjiri SatheBreakdown of academic impact, for papers by Martine ChabaudBreakdown of academic impact, for papers by Lisa G. M. van BaarsenBreakdown of academic impact, for papers by Shigeru IshiyamaBreakdown of academic impact, for papers by Liduine van den BersselaarBreakdown of academic impact, for papers by Stefan KuchenBreakdown of academic impact, for papers by Yojiro KawabeBreakdown of academic impact, for papers by Sylvie Ferrari‐Lacraz